Trial Profile
Retrospective comparative study of of new use of rivaroxaban and warfarin in the UK
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2020
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Warfarin
- Indications Cardiovascular disorders; Venous thromboembolism
- Focus Therapeutic Use
- 24 Sep 2018 New trial record
- 26 Aug 2018 Results presented at the 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management.